ARCHIVES

Grants Funding; NCI Restores Paylines To Last Year’s Levels

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

Organ Site Program Fate On Line, Gets Review Next Week

November 20, 1981

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005

Crizotinib Eliminated Tumors In 7 of 8 Children with ALCL

May 25, 2012

Canadian NCI Plans Review Of National Breast Screening Study

February 24, 1995

American Cancer Society Awards its Medal of Honor

May 24, 2013

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010